Ubs Group Ag Iradimed Corp Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Iradimed Corp stock. As of the latest transaction made, Ubs Group Ag holds 5,191 shares of IRMD stock, worth $399,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,191

Previous 9,112 43.03%

Holding current value

$399,032

Previous $478,000 35.15%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$48.67 - $60.8 $190,835 - $238,396	-3,921 Reduced 43.03%	5,191 $310,000
Q1 2025 May 13, 2025	SELL	$51.44 - $62.67 $549,790 - $669,816	-10,688 Reduced 53.98%	9,112 $478,000
Q4 2024 Feb 14, 2025	BUY	$48.3 - $57.35 $667,119 - $792,118	13,812 Added 230.66%	19,800 $1.09 Million
Q3 2024 Nov 14, 2024	BUY	$43.23 - $50.29 $54,469 - $63,365	1,260 Added 26.65%	5,988 $301,000
Q2 2024 Aug 13, 2024	SELL	$40.36 - $44.7 $151,228 - $167,490	-3,747 Reduced 44.21%	4,728 $207,000
Q1 2024 May 13, 2024	BUY	$41.17 - $47.29 $50,927 - $58,497	1,237 Added 17.09%	8,475 $372,000
Q4 2023 Feb 09, 2024	BUY	$37.31 - $47.47 $162,261 - $206,447	4,349 Added 150.54%	7,238 $343,000
Q3 2023 Nov 09, 2023	SELL	$43.28 - $50.3 $525,808 - $611,094	-12,149 Reduced 80.79%	2,889 $128,000
Q2 2023 Aug 11, 2023	BUY	$38.88 - $50.61 $286,545 - $372,995	7,370 Added 96.11%	15,038 $717,000
Q1 2023 May 12, 2023	SELL	$28.48 - $42.14 $64,023 - $94,730	-2,248 Reduced 22.67%	7,668 $301,000
Q4 2022 Feb 08, 2023	BUY	$26.9 - $30.58 $245,462 - $279,042	9,125 Added 1153.6%	9,916 $280,000
Q3 2022 Nov 10, 2022	SELL	$29.42 - $42.25 $17,710 - $25,434	-602 Reduced 43.22%	791 $24,000
Q2 2022 Aug 10, 2022	SELL	$30.15 - $45.79 $37,054 - $56,275	-1,229 Reduced 46.87%	1,393 $47,000
Q1 2022 May 16, 2022	BUY	$36.01 - $53.14 $6,265 - $9,246	174 Added 7.11%	2,622 $117,000
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $79,192 - $118,164	2,448 New	2,448 $113,000
Q3 2021 Nov 15, 2021	SELL	$29.5 - $37.21 $88 - $111	-3 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$24.04 - $29.79 $40,315 - $49,957	-1,677 Reduced 99.82%	3 $0
Q1 2021 May 12, 2021	BUY	$22.3 - $26.02 $11,952 - $13,946	536 Added 46.85%	1,680 $43,000
Q4 2020 Feb 11, 2021	SELL	$20.62 - $25.0 $4,371 - $5,300	-212 Reduced 15.63%	1,144 $26,000
Q3 2020 Nov 12, 2020	SELL	$21.0 - $24.61 $24,864 - $29,138	-1,184 Reduced 46.61%	1,356 $29,000
Q2 2020 Jul 31, 2020	SELL	$18.68 - $24.35 $39,302 - $51,232	-2,104 Reduced 45.31%	2,540 $59,000
Q1 2020 May 01, 2020	SELL	$16.08 - $27.67 $26,371 - $45,378	-1,640 Reduced 26.1%	4,644 $99,000
Q4 2019 Feb 14, 2020	BUY	$21.11 - $25.92 $30,123 - $36,987	1,427 Added 29.38%	6,284 $147,000
Q3 2019 Nov 14, 2019	BUY	$18.06 - $24.1 $10,944 - $14,604	606 Added 14.26%	4,857 $102,000
Q2 2019 Aug 14, 2019	BUY	$19.6 - $29.31 $53,606 - $80,162	2,735 Added 180.41%	4,251 $87,000
Q1 2019 May 14, 2019	SELL	$23.58 - $28.43 $919 - $1,108	-39 Reduced 2.51%	1,516 $43,000
Q4 2018 Feb 14, 2019	SELL	$20.63 - $34.04 $6,457 - $10,654	-313 Reduced 16.76%	1,555 $38,000
Q3 2018 Nov 14, 2018	SELL	$20.6 - $37.15 $3,234 - $5,832	-157 Reduced 7.75%	1,868 $69,000
Q2 2018 Aug 14, 2018	BUY	$14.15 - $20.75 $3,622 - $5,312	256 Added 14.47%	2,025 $42,000
Q1 2018 May 15, 2018	BUY	$13.0 - $15.8 $364 - $442	28 Added 1.61%	1,769 $25,000
Q4 2017 Feb 14, 2018	BUY	$10.0 - $15.7 $17,410 - $27,333	1,741 New	1,741 $26,000
Q3 2017 Nov 14, 2017	SELL	$9.4 - $10.55 $38,822 - $43,571	-4,130 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,564 Added 163.73%	4,130 $35,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,566	1,566 $14,000

Others Institutions Holding IRMD

# of Institutions

165

Shares Held

6.94M

Call Options Held

Put Options Held

4.2K

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $966M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account